
Overview
Ferron collaborates with partners across the world, and harnesses an extensive API-sourcing network as well as over 50 years of experience from the larger Dexa Group. Its facility has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA, the United Kingdom), Therapeutic Goods Administration (TGA, Australia), and the Federal Institute for Drugs and Medical Devices (BfArM, Germany).
Ferron has leveraged these assets to build a strong presence in Europe.
[1] IHPA+IPA 2005; IMS Audit 2005
Values
The name Ferron was inspired by the Latin ferreus (“made of iron”), as a reminder of the inner strength of the company’s values. The three sides of Ferron’s triangular logo represent its three core priorities: care, quality, and innovation.
Network
Services
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Capabilities
Development
Manufacturing
- Aseptic Fill Finish
- Ampoules
- Vials
- Pre-filled Syringes
- Non Aseptic Fill Finish
- Ampoules
- Vials
- Lyophilization
- Vials
- Bulk
- Dosage forms
- Semisolids
- Oral
- Sustained Release tablets
- Sustained Release pellets in capsules
- Liquid oral dosage form
- Advanced technology
- Automatic Liquid Inspection Machine
- Robotic Automatic Packaging System
- IoT-based Performance Monitoring System
- Packaging line with serialization system (as per the EU directive on falsified medicines)
Analysis
- Gas Chromatography with headspace
- Liquid Chromatography – UPLC and HPLC
- Dissolution Tester with automatic sampler
- FTIR
- UV/Vis
- Measurement of Water Content by Karl Fischer Titration
- Appearance
- pH measurement
- Osmolality
- Reconstitution Time
- Subvisible Particulate Matter
- TAMC/TYMC
- Antimicrobial Effectiveness Test (AET)
- Bioburden
- Endotoxin
- Sterility-closed system with isolator